Category: Ria Kits

The Road so Far in Colorectal Cancer Pharmacogenomics: Are We Closer to Individualised Treatment?

In the past few decades, the survival rate in colorectal cancer has increased rapidly due to pharmacological treatment. However, many patients finally develop a detrimental […]

Continue reading

Oncology and Pharmacogenomics Insights in Polycystic Ovary Syndrome: An Integrative Analysis

Polycystic Ovary Syndrome (PCOS) is a heterogeneous endocrine disorder characterized by hyperandrogenism, ovulation dysfunction, and polycystic ovaries. Epidemiological findings reveal that women with PCOS tend […]

Continue reading

Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression

We evaluate the clinical validity of the pharmacogenomic test combination and the implementation guidelines for single clinical pharmacogenetics (CPIC) on patient outcomes and blood levels […]

Continue reading

Apremilast Pharmacogenomics in Russian Patients with Moderate-to-Severe and Severe Psoriasis

One target drug for plaque psoriasis treatment is apremilast, which is a phosphodiesterase 4 (PDE4) inhibitor selective. In this study, 34 patients with moderate and […]

Continue reading